DRL launches omeprazole and sodium bicarbonate capsules in US
A therapeutic equivalent of ZEGERID capsules, DRL's offerings are are available in bottle count size of 30
Dr Reddy’s…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Sugar-binding protein galectin-9 found to be a new weapon to cure HIV
It potently forces latent HIV out of hiding, and poisons the virus on its way out
Biocon’s insulin Glargine launched in Japan
The company through its partner aims to capture a significant share of the Japanese Glargine market
FDA approves dedicated syringe for use with Humulin R U-500 insulin
It is is the only device approved for use with U-500 insulin vial
Sun Pharma launches Gemcitabine InfuSMART, RTA bag for oncology treatment
Developed by Sun Pharma’s R&D team in India, InfuSMART will be rolled out across six countries - Netherlands, UK, Spain,…
Conference on drug counterfeiting organised in Mumbai
PatientSafe India addresses various aspects of drug counterfeiting and suggested creative ways to raise awareness and devise…
Cipla to launch biotech manufacturing facility in South Africa
Construction is scheduled to start in early 2017, with full operations expected to commence in the third quarter of 2018
Lupin receives EIR from US FDA for Goa, July 2015 inspection
The responses from March 2016 US FDA inspection are still under review
GIPC co-hosts session with AMCHAM on India’s National IPR Policy
Global innovators highlight the ability of strong IP protections to drive innovation and the need for an action-oriented approach…
Indian Immunologicals organises vaccination camps to eradicate zoonotic diseases
Nearly a total of one lakh doses of RAKSHARAB – a rabies vaccine produced by the company was administered free of cost in all the…